Bio-Rad Laboratories - 45 Year Stock Price History | BIO
- The all-time high Bio-Rad Laboratories stock closing price was 825.77 on September 02, 2021.
- The Bio-Rad Laboratories 52-week high stock price is 387.99, which is 57% above the current share price.
- The Bio-Rad Laboratories 52-week low stock price is 211.43, which is 14.4% below the current share price.
- The average Bio-Rad Laboratories stock price for the last 52 weeks is 298.80.
Bio-Rad Laboratories Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 267.4898 | 326.1600 | 367.0000 | 216.5600 | 247.0600 | -24.79% |
2024 | 319.1788 | 327.9900 | 374.2800 | 263.9700 | 328.5100 | 1.74% |
2023 | 393.2294 | 422.4300 | 503.0000 | 269.3700 | 322.8900 | -23.21% |
2022 | 505.9841 | 735.4200 | 735.4200 | 351.7100 | 420.4900 | -44.35% |
2021 | 675.8090 | 575.2600 | 825.7700 | 547.0100 | 755.5700 | 29.61% |
2020 | 472.1816 | 372.1600 | 643.4500 | 320.0100 | 582.9400 | 57.54% |
2019 | 312.5641 | 228.0800 | 374.2000 | 224.3000 | 370.0300 | 59.34% |
2018 | 277.5328 | 241.4200 | 326.1500 | 220.1000 | 232.2200 | -2.70% |
2017 | 219.5758 | 182.9100 | 271.3000 | 182.9100 | 238.6700 | 30.94% |
2016 | 149.1690 | 136.1900 | 183.4600 | 123.9300 | 182.2800 | 31.46% |
2015 | 137.5260 | 120.3500 | 151.9300 | 113.7700 | 138.6600 | 15.01% |
2014 | 120.8765 | 122.6500 | 133.7300 | 106.4800 | 120.5600 | -2.47% |
2013 | 118.6682 | 107.4600 | 126.0000 | 107.4600 | 123.6100 | 17.67% |
2012 | 102.7218 | 98.0800 | 114.2500 | 92.3000 | 105.0500 | 9.38% |
2011 | 108.0200 | 105.3200 | 126.3400 | 87.5400 | 96.0400 | -7.52% |
2010 | 94.7088 | 97.8700 | 113.6300 | 81.5000 | 103.8500 | 7.66% |
2009 | 78.5782 | 74.4700 | 100.4600 | 53.1000 | 96.4600 | 28.08% |
2008 | 87.1254 | 99.9700 | 108.1000 | 61.5200 | 75.3100 | -27.32% |
2007 | 82.9541 | 82.2200 | 107.5700 | 67.6700 | 103.6200 | 25.57% |
2006 | 68.9380 | 65.4500 | 84.0100 | 57.2500 | 82.5200 | 26.10% |
2005 | 55.5089 | 57.1700 | 66.9000 | 47.0600 | 65.4400 | 14.07% |
2004 | 55.2252 | 58.4100 | 61.9000 | 50.0100 | 57.3700 | -0.52% |
2003 | 48.0377 | 38.2100 | 62.1500 | 33.4000 | 57.6700 | 49.02% |
2002 | 39.7467 | 30.9000 | 50.5100 | 28.1250 | 38.7000 | 22.27% |
2001 | 23.7924 | 16.0500 | 32.5250 | 15.0750 | 31.6500 | 99.06% |
2000 | 12.9793 | 11.3125 | 16.7450 | 10.6250 | 15.9000 | 36.04% |
1999 | 12.2612 | 10.3125 | 14.5000 | 9.4375 | 11.6875 | 11.31% |
1998 | 13.1470 | 13.0625 | 16.8750 | 9.8750 | 10.5000 | -19.62% |
1997 | 13.5673 | 15.1875 | 16.3750 | 11.8125 | 13.0625 | -12.92% |
1996 | 14.6823 | 14.2083 | 18.3125 | 12.1250 | 15.0000 | 5.88% |
1995 | 11.3629 | 9.1250 | 14.1667 | 8.4583 | 14.1667 | 53.15% |
1994 | 6.4239 | 3.5000 | 9.6250 | 3.5000 | 9.2500 | 177.50% |
1993 | 4.7749 | 5.7083 | 5.9167 | 3.3333 | 3.3333 | -41.61% |
1992 | 6.1821 | 6.4167 | 7.1250 | 5.3750 | 5.7083 | -13.29% |
1991 | 7.0525 | 6.0833 | 9.1667 | 5.5417 | 6.5833 | 6.76% |
1990 | 5.8093 | 5.4167 | 7.6667 | 4.2083 | 6.1667 | 15.63% |
1989 | 5.6551 | 5.7083 | 6.5417 | 4.7500 | 5.3333 | -5.88% |
1988 | 6.3804 | 5.2500 | 7.7083 | 4.9167 | 5.6667 | 11.48% |
1987 | 7.6194 | 5.8750 | 10.6667 | 3.7500 | 5.0833 | -11.59% |
1986 | 5.9523 | 5.0556 | 7.6389 | 4.5556 | 5.7500 | 13.74% |
1985 | 3.2332 | 2.1296 | 5.3056 | 2.1296 | 5.0556 | 137.40% |
1984 | 2.2030 | 2.5000 | 2.5185 | 2.0741 | 2.1296 | -14.82% |
1983 | 2.3316 | 1.3519 | 2.8704 | 1.3519 | 2.5000 | 87.50% |
1982 | 1.3125 | 1.5370 | 1.6111 | 0.8704 | 1.3333 | -7.69% |
1981 | 2.4658 | 2.9815 | 3.6667 | 1.2963 | 1.4444 | -51.25% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $6.846B | $2.567B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
Boston Scientific (BSX) | United States | $154.336B | 38.64 |
Stryker (SYK) | United States | $150.874B | 31.55 |
EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
Medtronic (MDT) | Ireland | $113.364B | 16.07 |
Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
ResMed (RMD) | United States | $37.677B | 28.30 |
GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
Agilent Technologies (A) | United States | $34.480B | 22.48 |
Terumo (TRUMY) | Japan | $25.244B | 32.79 |
Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
Insulet (PODD) | United States | $21.186B | 83.16 |
Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
Baxter (BAX) | United States | $15.914B | 11.88 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
Demant (WILYY) | Denmark | $8.971B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
Haemonetics (HAE) | United States | $3.693B | 16.82 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.456B | 28.72 |
ICU Medical (ICUI) | United States | $3.333B | 24.58 |
QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
AtriCure (ATRC) | United States | $1.572B | 0.00 |
Acuren (TIC) | United States | $1.378B | 0.00 |
AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
Neogen (NEOG) | United States | $1.157B | 14.81 |
Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
InMode (INMD) | Israel | $0.958B | 9.66 |
Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
Owens & Minor (OMI) | United States | $0.712B | 5.90 |
CeriBell (CBLL) | United States | $0.684B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
Evolus (EOLS) | United States | $0.598B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
Valneva SE (VALN) | France | $0.494B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
Surmodics (SRDX) | United States | $0.429B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
Quanterix (QTRX) | United States | $0.349B | 0.00 |
SNDL (SNDL) | Canada | $0.334B | 0.00 |
Cerus (CERS) | United States | $0.294B | 0.00 |
ZimVie (ZIMV) | United States | $0.285B | 12.98 |
Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
Brainsway (BWAY) | Israel | $0.250B | 66.20 |
Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
Biote (BTMD) | United States | $0.231B | 6.49 |
OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
Organigram Global (OGI) | Canada | $0.192B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
High Tide (HITI) | Canada | $0.188B | 0.00 |
Omeros (OMER) | United States | $0.188B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
Exagen (XGN) | United States | $0.150B | 0.00 |
Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
Jin Medical (ZJYL) | China | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.097B | 12.48 |
MacroGenics (MGNX) | United States | $0.092B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Apyx Medical (APYX) | United States | $0.087B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
Zynex (ZYXI) | United States | $0.073B | 0.00 |
InterCure (INCR) | Israel | $0.071B | 0.00 |
Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.068B | 0.00 | |
Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.058B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 57.57 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.86 |
Safety Shot (SHOT) | United States | $0.030B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.012B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |